← All posts
Business 18 Nov 2026 Market news

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

Read the full story ↗